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Introduction  
The term ‘life course epidemiology’ was coined in 1997 with the publication of the first 
edition of ‘A life course approach to chronic disease epidemiology’.1  This book reviewed the 
pre-adult risk factors for cardiometabolic and respiratory disease, the catalyst being the 
imaginative research on the fetal origins of adult disease being driven forward at that time by 
Professor David Barker. We defined life course epidemiology as ‘the study of long-term 
biological, behavioural, and psychosocial processes that link adult health and disease risk to 
physical or social exposures acting during gestation, childhood, adolescence, earlier in adult 
life, or across generations’.1  Whilst our definition of life course epidemiology has stood the 
test of time, the field has evolved and there have been conceptual developments, 
methodological innovations which facilitate efforts to test these concepts, and an increasing 
corpus of empirical research demonstrating how factors from earlier life are associated with 
later life health and disease, as well as the pathways and biological mechanisms that may be 
involved. These developments have generated further ideas and challenges to life course 
models in an iterative process.  As the theme of this special issue suggests, one important 
development has been the gradual shift of research focus from clinical disease end-points to 
multi-faceted traits and longitudinal trajectories of functional phenotypes that can be assessed 
well before any clinical threshold is reached. This has naturally led on to the application of a 
life course epidemiological approach to ageing.  The purpose of this overview is therefore to 
assess the development and current state of the field of life course epidemiology, including its 
recent application to the study of ageing as the focus of this special issue.   
 
Developments in the field of life course epidemiology  
Life course epidemiology is now recognised as a field of research in its own right and was 
added to the fifth edition of the Dictionary of Epidemiology.2 The original life course book 
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was to become the first in a series on a life course approach to adult health,3-8  as well as a 
journal glossary9 and chapters in a range of public health, epidemiology and other academic 
textbooks.10-14  The original International Journal of Epidemiology editorial on life course 
epidemiology published in 200215  is the 5th most highly cited article in the journal’s history 
(search run on Web of Science core collection 19/02/2016).  
 
In order to chart key developments in the field, we have drawn on our own experiences and 
the results of three literature searches: i) a cited reference search of four key conceptual life 
course publications,1 4 15 16 Medline searches for publications including the terms (ii) ‘life 
course’,  and (iii) ‘developmental origin’ or ‘fetal origin’ (see text box).  
 
We have, from the outset, highlighted the long term history of life course concepts and the 
fact that disciplines outside of epidemiology, such as demography, sociology, anthropology  
and psychology, have considered these broad ideas for longer.3 9 15 16 17 (see commentary by 
Alwin in this issue18). It was thus no surprise that our literature searches, even when restricted 
to Medline, returned empirical as well as narrative and review papers from journals in these 
disciplines as well as epidemiology and public health, highlighting the broad appeal of a life 
course perspective.  Alwin18 19 20 discusses the conceptual and methodological developments 
and the growth of empirical evidence in these other fields and draws parallels with the 
developments in epidemiology.  
 
Life course perspectives in epidemiology were eclipsed in the mid-twentieth century by the 
almost exclusive focus on the adult lifestyle model of disease causation.21 The catalyst for the 
revival of life course thinking in epidemiology was the seminal work of David Barker and 
colleagues on the fetal origins of adult disease (FOAD)22 from the late 1980s which was 
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subsequently extended to the developmental origins of health and disease (DOHaD) at the 
turn of the century.23 24  The first of three phases in the development of life course 
epidemiology reflects this; a focus on the associations of early life factors with clinical 
disease end-points.  Life course epidemiology is often incorrectly interpreted as being 
synonymous with DOHaD but there are both similarities and differences (see below) and 
interestingly there was only limited overlap found between publications in these two fields 
(see figure 1).   
 
We consider the second main phase in the development of life course epidemiology to be the 
expansion of the field to consider a wider range, and more integrated study, of outcomes, 
including different aspects of physiological function and their natural history across life, and 
of biological, psychological and social risk factors acting independently, cumulatively or 
synergistically across different life stages.  These developments were possible because of the 
growing number of birth cohort and other longitudinal studies with increasingly rich data 
archives, and the development of life course methods that facilitated such analyses. The study 
of functional measures is discussed further below and this shift, alongside maturation of 
cohort studies with relevant data, has led to the third and most recent phase in the 
development of life course epidemiology; the application of a life course epidemiological 
approach to the study of ageing.  
 
There remains a healthy appetite for life course epidemiology after almost 20 years and many 
of the ideas proposed and subsequently developed remain scientifically innovative and policy 
relevant. This is supported by evidence of a year on year increase in the number of papers that 
cite one of the four key  references  or use ‘life course’ in their title or abstract (see figure 2).  
However, some caution is required as there has been a secular increase in the number of 
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scientific publications in general and, when classifying abstracts we observed that the term 
‘life course’ is sometimes used loosely and occasionally inappropriately. This supports the 
assessment made by Alwin in his review of life course concepts in social sciences that life 
course, “has become a catch all term, taken to refer to all manner of different aspects of 
individual experiences in biographical time.”18 19 In addition, it was noted that a number of 
papers use the term ‘life course’ in their abstract despite not applying this approach, rather 
they have concluded that this may be useful in future research.  In contrast, some of our own 
papers, that we would describe as examples of life course epidemiology, were not captured by 
the searches, as titles and abstracts of epidemiological papers generally focus on reporting 
study design, exposures and outcomes and do not necessarily report the conceptual approach 
taken; a limitation with current structured abstracts and indexing. 
 
Despite these caveats, we identified trends in the published literature which supported our 
observations on the key phases of development in the field, and also provided evidence of the 
balance between papers reporting empirical studies and other types of papers. In the case of 
empirical studies, we tried to capture the types of outcomes and exposures and the settings in 
which the studies took place. Key points are briefly summarised here, and relevant points and 
publications uncovered by these searches are cited throughout the paper. Approximately 60% 
of the classifiable papers identified by our Medline search for publications that included the 
term ‘life course’ in their title and/or abstract (i.e. search 2) reported quantitative empirical 
analyses (for breakdown of types of paper see supplementary tables 1 and 2).  Among these 
empirical papers there was evidence that studies of metabolic conditions (including obesity 
and diabetes),  cardiovascular and socioeconomic outcomes were the most commonly 
investigated across all years; as were studies of  mental health25-27 where there has been a 
longstanding parallel interest in the life course or life span perspective.  There was evidence 
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of a diversification in the types of outcomes being studied over time with more recent 
empirical papers reporting life course analyses of a wider range of outcomes including cancer, 
musculoskeletal disorders, disability, oral health, injury, infectious diseases, migration, 
genetic and epigenetic markers and age-related phenotypic trajectories. There were also a 
number of papers reporting on behaviours as outcomes: here cigarette smoking, alcohol 
consumption and physical activity were common but other topics included marijuana use and 
criminal behaviours, with several investigating these behavioural trajectories over different 
life stages.28-31 In terms of exposures, there has been an increase over the past ten years in the 
proportion of empirical studies which model exposures as repeat measures or trajectories 
covering multiple life stages.  The impact of an adverse socioeconomic environment in 
childhood and adulthood on later outcomes remained an enduring theme perhaps because 
such exposures more easily lend themselves to being modelled within a life course 
framework, have been collected relatively frequently across life and can be retrospectively 
ascertained by a variety of methods. The impact of early psychosocial environment, gender, 
body size and shape, and behavioural risk factors also appear to be persistent topics.  In terms 
of setting, the majority of studies are based in the UK, mainland Europe and the US, which 
has been facilitated by the availability of data from maturing birth and historical cohort 
studies, particularly in the UK.32 More recently, there has been an increase in the number of 
studies set in other high income countries and also a rise in relevant studies being conducted 
in low and middle income countries (see commentary by Steve Tollman33).  The broadening 
of study settings is essential to help establish which life course associations are contextual and 
which are universal.  A small but increasing number of papers involved multiple cohorts (see 
below) which sometimes crossed several of these settings.  
 
From FOAD to DOHaD and the life course 
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We have always acknowledged the importance of the “Barker hypothesis” or FOAD model as 
a stimulus for life course epidemiology. We viewed this as one set of competing and 
innovative aetiological models that needed to be tested alongside others. In addition, as 
population scientists, understanding temporal, geographical and social differences in disease 
risk is important, as well as elucidating more fundamental downstream mechanisms that may 
explain epidemiological associations. We note that the term “life course” has gained 
popularity in the DOHaD world, (anecdotal observation at 8th World Congress on DOHaD, 
Singapore) and the term ‘life course biology’ has been used by DOHaD colleagues,34 so it is 
important to understand what are the substantive similarities and differences in approaches. 
 
The DOHaD model proposes that responses to the impact of any environmental challenge can 
be seen to operate over different time scales: (a) homeostasis is the immediate response; (b) 
predictive adaptive response (PAR) occurs in earlier life and maximises the chances of 
survival and reproduction and; (c) natural selection occurs over many generations.24 35 36 
Chronic disease may arise where a PAR is maladaptive in the long term, e.g. a PAR to a 
nutrient-poor environment in childhood will be counter-productive if the adult environment is 
obesogenic and so could lead to type II diabetes. This is analogous to the “antagonistic 
pleiotropy” model of ageing, whereby pleiotropic genes with good early effects would be 
favoured by selection even if these genes had bad effects at later ages as long as the organism 
had successfully passed on these genes to future generations.37 The “live fast, die young” 
strategy is successful when there are strong external influences on mortality so that few 
survive much beyond reproductive age. Both models assume that survival into later life has 
no benefits on the survival advantage of first or even second generation offspring. This may 
not be true for human societies where kinship networks can play an important role in the 
health and wellbeing of children and grandchildren, especially in low and middle income 
8 
 
countries where the ravages of HIV infection have left generations of children dependent on 
grandparents for care. We agree with a recent DOHaD review paper37 which argued that the 
early use of the term “programming” was unhelpful in implying an overly deterministic view 
of DOHaD, and was not supported by the empirical evidence. 
 
Scientists concerned with life course epidemiology or the DOHaD approach share many 
common research interests, especially in understanding how developmental factors are 
associated with adult function and disease, but there are important differences. Life course 
epidemiology is equally interested in the maintenance of function or its rate of decline post 
maturity and the factors across the whole of life that determine this. The focus of DOHaD is 
on developmental mechanisms within an evolutionary framework, but while this framework is 
a scientific strength and is widely relevant to many outcomes, research has focused on the 
developmental origins of chronic diseases, especially cardiometabolic diseases.  In contrast, 
life course epidemiology with its public health background, remains interested in both social 
and biological pathways, and has been applied to a wider variety of outcomes, as evidenced 
by our literature searches. DOHaD, despite its growing interest beyond the immediate post-
natal period, has focussed on interventions in young and/or pregnant women, or in infancy, 
generally with a biomedical emphasis, and has been somewhat dismissive of the potential for 
later life interventions to modify disease risk or alter disease progression. A life course 
approach is essentially agnostic and tries to provide empirical evidence to guide the most 
appropriate timing of any intervention, be it at a biomedical, individual or societal level, to 
maximise population health. Whilst the DoHAD approach has been more successful in 
engaging the basic science community, the life course approach has also benefitted from 
inter-disciplinary interactions with basic scientists; for example, research relating to the 
insulin like growth factor cancer inter-relationship and how it has influenced life course 
9 
 
studies in human populations.(summarised in reference12) The commentary by Boyce and 
Shonkoff 38 reinforces the need to triangulate life course epidemiology with mechanistic 
insights from biology. We believe that both approaches have much to offer each other, despite 
the limited overlap in the literature to date (see figure 1), and anticipate further convergence 
in how ideas from both camps can be used to cross-fertilise future research (see commentary 
by Hanson and Gluckman for further discussion39).  
 
Revisiting life course models  
In our original work we proposed several conceptual models such as critical/sensitive period 
models, as exemplified by DOHaD, and accumulation or chains of risk models which are 
more common in the social epidemiology literature. We illustrated these ideas graphically 
using simplified causal diagrams, though at this time we were unaware of the growing 
literature on directed acyclic graphs (DAGs),40 41 (see commentary by De Stavola and 
Daniel42 for a more detailed discussion of causal inference in relation to life course concepts 
and VanderWeele’s unified approach to decomposing exposure outcome relationships in the 
presence of mediators and potential interactions43). Initially these critical periods and 
accumulation models were presented as different classes of models, though we have since 
noted11 that it is more sensible to view critical or sensitive period models as special sub-sets 
of an accumulation model when considering the effects of an exposure over time  – hence the 
effects of exposures over different time periods do not add up in a simple additive fashion but 
differ in the strength of effect in a quantitative sense (sensitive period) or in a qualitative 
sense so that they can only be observed in one time period (critical period) (a point also made 
by Alwin20).  
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In our initial work, we had conceptualised an accumulation of risk as the incremental burden 
of different exposures with age and highlighted the issue of clustering of exposures. However, 
our literature searches highlight that most papers that try to address this model actually use 
the cumulative exposure of a single exposure, such as periods of adverse social 
circumstances, in a quantitative fashion.  This is a standard epidemiological approach (“dose-
response effect”) and of particular interest to occupational or environmental epidemiology.  
Even here, arguments persist as to how best to model the functions of intensity and duration.44 
A life course approach highlights the importance of timing over and above cumulative 
exposure. We have illustrated this with a simple figure (see figure 3) examining the 
relationship between pack years of smoking exposure and breast cancer risk. A conventional 
dose-response model would be consistent with an accumulation model. However, it would fail 
to recognise a sensitive period model if it did not consider whether initiation of smoking 
during puberty or post-pubertally altered the risk conditional on smoking intensity and 
duration.45  Of course there may be other potential mechanistic pathways so that early and 
intense smoking may itself predict exposure to smoking at the time of disease onset and hence 
the induction may be relatively short but predicted by early smoking behaviour. 
 
Many contemporary papers have formally modelled trajectories of exposure, especially those 
examining anthropometric exposures, using a variety of statistical approaches (for example 
two-stage spline models, latent class models, multilevel models, SITAR - see reference Tu et 
al 201346 for a review of this area and accompanying commentary by Hardy and Tilling47) to 
see whether different exposure patterns are associated with risk. As an exemplar, one can then 
pose the question as to whether the chronic disease risk associated with midlife obesity is 
different for those sub-groups who have always been at the upper end of the body mass index 
(BMI) distribution and have tracked into adulthood versus those who were born underweight 
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and gained weight in childhood, early or mid-adulthood. An alternative has been to use a 
Mendelian Randomization approach which uses genetic markers as instruments for 
behavioural or phenotypic variability thereby exploiting the random allocation of parental 
genotype and avoiding issues of confounding and reverse causation.48-50  
 
The notion of a critical/sensitive period was initially framed around early life, stimulated by 
FOAD. It is increasingly being shown that biological and social transitions during other life 
stages are also likely to be sensitive periods where adverse exposures may have more impact 
than at other times, as birth cohort studies have matured, and cohorts with rich data on 
adolescence, young adulthood and mid-life51-53 have emerged. For example, the timing of the 
pubertal growth spurt appears to be important for levels of insulin-like growth factor-I,51 
breast cancer risk,54 and trabecular volumetric bone mineral density.55 Accelerated increases 
in blood pressure across early and mid-adulthood are associated with a greater left ventricular 
mass index and indicators of diastolic dysfunction in early old age.56 Identifying sensitive 
periods can be difficult but will be helped by a better understanding of phenotypic/functional 
trajectories (see below) as inflection or turning points in a trajectory, may highlight the 
greater value of an intervention, assuming this is at least partially modifiable and driven by 
concurrent exposures. 
 
Life course models have also stimulated statistical methods to help differentiate between 
various competing models. These have used nested models,57 causal inference algorithms,58  
least angle regression,59 structural equation models 60 and marginal structural models.61 Any 
life course model which considers exposures, confounders and potential intermediaries is 
bedevilled by the problem of time varying confounders and “intermediary confounders”62  i.e. 
a confounder of a mediator which is itself affected by the exposure and hence also acts as an 
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intermediary. This problem is not specific to life course epidemiology but is obviously more 
problematic when examining exposures acting over a long time period, for example when 
testing whether cognitive function in adulthood is associated with mortality rates given the 
large number of social and behavioural covariates that could act in several different ways.63 
 
The drivers and consequences of functional change 
The original life course models generally assumed a fixed outcome, such as disease diagnosis 
at a point in time. However, as noted above, lifetime trajectories of functional phenotypes are 
increasingly being studied as outcomes. This shift in focus has been driven in part by our 
initial work which put forward hypothetical phenotypic trajectories, adapted from Strachan’s 
review of lung function in the original life course textbook.64 These illustrate how the same 
disease end-point could be reached through either sub-optimal development or accelerated 
decline or a combination of both.  At that time these patterns were hypothetical but recent 
data have identified that around half of all cases of chronic obstructive pulmonary disease 
occur in individuals with sub-optimal adult lung function but normal age-related decline, 
whilst the other half occur after normal development of lung function with an accelerated 
decline phase.65 This simple figure highlighted two important messages: (a) that 
epidemiologists should consider continuous traits, such as lung, cognitive or muscle function 
and complex phenotypes such as ageing, as well as binary phenotypes and (b) that classifying 
disease end-points at one time period, usually in later life, ignores the underlying trajectories 
thereby increasing phenotypic heterogeneity. This will attenuate risk factor associations if 
they are only of causal relevance for some sub-groups but not others. The same argument has 
been made for understanding phenotypic variability in relation to genetic association 
studies.66 Using functional outcomes also has the benefit of facilitating the study of pre-
clinical disease and identifying high risk sub-groups through risk stratification; functional 
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outcomes may have more statistical power; they demonstrate the dynamic nature of disease 
aetiology with periods of recovery as well as loss; and they can be used for clinical triage.  
Being able to detect early markers of sub-optimal development and/or an accelerated 
trajectory of functional decline before it is clinically manifest is fundamental to a life course 
perspective because it offers an opportunity to delay the rate of decline and/or the onset of 
functional impairments through preventive strategies.  How these trajectories differ with 
person (age, gender, social circumstances), place (geography) and time (birth cohorts) may all 
provide important mechanistic and aetiological clues for further investigation. 
 
Where the drivers of functional change are themselves changing over time, joint modelling of 
both trajectories of exposure and phenotype, and their inter-relationship is required.67 For 
example, data from the ALSPAC birth cohort has been used to model how maternal change in 
blood pressure during pregnancy may relate to offspring blood pressure trajectories between 7 
to 18 years using bivariate linear spline models.68 In this case there is no problem with 
temporality as offspring trajectories cannot influence maternal patterns. However, when 
studying functional trajectories that may be occurring simultaneously, for example, cognitive 
and physical function, it is unclear which should be regarded as the driver and which the 
consequence; indeed both may drive each other.69 The hypotheses to test may be taken for 
theoretical and pragmatic reasons, such as the ages when data points are available; however 
interpretation of findings needs to acknowledge the inherent challenges of identifying the 
temporal ordering in these situations.   
 
The research evidence on functional change within a life course context is less developed (see 
this reference70 for evidence of change in cardiometabolic outcomes). It has been harder and 
more costly to achieve due to the requirements for multiple and frequent measures, though 
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this may be changing due to technological innovations. Not surprisingly this has resulted in 
gaps around several important questions. So, for example, to what degree do earlier life 
factors that have been previously shown to be associated with the level of adult function, also 
drive functional change or is the association merely due to the maximal level attained through 
developmental factors? Smaller birth weight is associated with higher blood pressure but this 
does not appear to amplify with age suggesting that the age-related increase is similar 
regardless of birth weight. 70 71 In contrast early adverse social circumstances are associated 
with greater increases in blood pressure in midlife,72 perhaps  through an influence on BMI 
gain. 
 
One of the inherent problems of characterising lifetime functional trajectories and their inter-
relationships, is the need for longitudinal data across the whole life course, which is rarely 
available. Alternatives include the use of cross-sectional data from a single study with a very 
wide age range or the creation of a synthetic birth cohort by combining cross-sectional and/or 
longitudinal data from multiple cohorts covering different age ranges usually with some 
overlap. Both approaches have been undertaken to establish normative data on grip strength 
across life.73-75 To understand within person change, one must combine longitudinal data 
across different ages as was undertaken by Wills et al76 using blood pressure data from eight 
British cohort studies.  Interestingly participants in the only occupational cohort (Whitehall II 
study) had a more moderate/less marked midlife increase in blood pressure, suggesting 
modifiable social determinants, unless this was due to selection bias. By drawing together 
data from different cohorts, alcohol consumption patterns have also been shown to change 
with age in a similar way for men and women, but men have a higher peak level.77 
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By concatenating data from overlapping age groups from different cohorts,73 or simply using 
cross-sectional data covering a wide age range,74 75  we are assuming that there are no period 
or cohort effects which may not be true. This can be formally tested when different birth 
cohorts with data across the same age periods are directly compared to each other. Johnson et 
al78 harmonised repeat measures of body size from five British birth cohorts from the 
CLOSER consortium, born in 1946, 1958, 1970, 1990-2 and 2001, and showed that the 
probability of being overweight or obese increased rapidly after childhood in the oldest three 
cohorts; the probabilities of overweight in the two younger cohorts at 11 years were already 
double those in the three older cohorts; and that the shifts in age-related overweight or obesity 
trajectories across these cohorts was due to BMI being positively skewed in the more recent 
cohorts.  The earlier onset of obesity78 and hence greater obese life years79-81 in more recent 
cohorts can be used to predict future disease burden and demands on health service delivery.  
Such cross-cohort collaborations with reanalysis of individual participant data are extremely 
valuable but technical issues around data harmonization as well as the important assumptions 
when aggregating data should not be under-estimated. 
 
The challenge of ageing research for life course epidemiology 
Applying life course ideas to ageing research has made us reconsider and modify some of our 
earlier, simpler life course models. How one defines and measures ageing remains debated 
with much interest in developing biomarkers82 of  biological as opposed to chronological age. 
These can be single biological markers of a cellular process e.g. telomere length or epigenetic 
clock,83 but are more often composite markers that aggregate determinants and/or 
consequences of ageing.84 In each case the aim is to demonstrate that the marker has added 
value in predicting other outcomes, such as mortality, morbidity or function, over and above 
chronological age. The predictive value of these markers may differ at different stages of the 
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life course and may not necessarily remain constant over secular period; and as with any other 
markers of continuous traits that show population variation and age-related changes, they 
should be studied from a life course perspective (see commentary by Moffitt and 
colleagues85).  
  
We have noted that there is a lot of confusion about what is meant by the term “healthy 
ageing”, partly because researchers are trying to do two things. Some researchers include any 
dimension of the health and wellbeing of older people regardless of whether the health 
dimension under study changes adversely with age. Others, including ourselves,5 separate out 
healthy biological ageing from how people feel or function socially, preferring to study their 
bi-directional relationships, rather than derive some composite healthy ageing index. Ageing 
is expressed as a failure to maintain structural or functional integrity leading to system failure 
and ultimately death. Healthy biological ageing covers three key longitudinal components: 
survival to old age, delay in the onset of age-dependent diseases, and maintenance of optimal 
functioning for the maximum period of time.  We distinguish three levels of functioning that 
all generally show a decline with age: capability describes physical and cognitive functioning 
at the individual level, and is defined as the capacity to undertake the physical and mental 
tasks of everyday living; the physiological functioning of each body system; and the 
underlying functioning of molecules and cells. Studying the lifetime trajectories of these 
different aspects of functioning, their dynamic interplay over time, and their lifetime 
environmental and genetic determinants has become a major focus in life course 
epidemiology.   
 
Ferrucci and Studenski86 have proposed a model for understanding frailty or healthy life 
expectancy that focuses on four key ageing phenotypes: (i) central nervous system (CNS) 
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integrity or neurodegeneration; (ii) homeostatic regulation or age-related dysregulation in 
signalling pathways that maintain homeostasis (encompassing both the endocrine and 
immunological systems); age-related changes in (iii) body composition (muscle, fat and 
bone); and (iv) energy capacity and consumption.  We have incorporated these themes into an 
integrated life course model of ageing (see figure 4). We have also added reproductive ageing 
(not normally considered by gerontologists), given the importance of development and 
reproduction from an evolutionary perspective and emotional health which itself may be a 
determinant and/or consequence of ageing but is important for social participation and quality 
of life. A woman’s physiological response to the challenge of pregnancy and childbirth 
provides insights into adaptive capacity, and reproductive characteristics (such as gestational 
diabetes, offspring low birth weight, and early menopause) may act as sentinels for later 
disease and accelerated ageing.87 
 
We delineate six phases of life (conception, pre-natal, pre-pubertal, pubertal, maturity and 
senescence) though recognise the importance of inter-generational influences through genetic, 
epigenetic or social transmission. The other dimensions are what we refer to as the external 
and internal environments, the former referring to the social and physical milieu which will in 
turn influence and interact with the latter. This may operate via direct physiological change 
e.g. weight loss due to famine or through internal adjustment or modification e.g. down 
regulation of the growth hormone insulin like growth factor axis in relation to dietary 
exposure,88 analogous to the PAR with potentially long term adverse or beneficial 
consequences.   
 
Not surprisingly these are dynamic systems with feedback loops that can operate in both 
negative and positive ways to either maintain stability and homeostasis or to increase 
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deviation and increase instability, a feature seen in ageing systems. Our own work89 used 
simple epidemiological measures of physical and cognitive capability, and emotional 
wellbeing as these are easy to measure in large scale epidemiological studies. Co-morbid 
disease such as chronic obstructive pulmonary or cardiovascular disease will usually impact 
on these measures as well as influencing body composition and energetics. CNS integrity is 
clearly important for cognitive function but also plays roles in physical capability through 
neuromuscular coordination and through endocrine and autonomic pathways. The “common 
cause hypothesis” argues that ageing is associated with decline across multiple systems  
through common aetiological mechanisms be they genetic or environmental. This may not 
always be evident as the rate of decline may differ across domains so that one system e.g. 
cognitive decline may appear to be more dominant even though physical decline is also 
present. Some evidence exists for the common cause hypothesis though a recent systematic 
review69 found only modest evidence and issues around comparability between studies.   
 
The stochastic nature of ageing means that this integrated life course model is unlikely to 
predict individual outcomes with much certainty, but it may explain group differences in 
ageing.90 This generic model had three phases: (a) growth; (b) plateau; and (c) degeneration, 
analogous to Baltes’ allocation of resources across the life course with allocation of resources 
towards growth in childhood, maintenance and recovery (resilience) in adulthood and 
regulation or management of loss in old age91 (see also commentary by Alwin18). This simple 
pattern may not always apply; for example systolic blood pressure shows an accelerated 
increase with age with a possible decline by the eighth decade.76 It is possible to reconcile this 
divergent pattern by reconceptualising the phenotype to be arterial elasticity, rather than 
systolic blood pressure. This will decrease with age, hence resulting in increased systolic 
blood pressure.  The apparent decrease in blood pressure in later life, assuming this is not a 
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treatment effect, is not due to increased elasticity, but more likely reflects a different 
pathophysiological mechanism such as declining autonomic control on vascular tone. 
However, this generic pattern may not be true for all systems and structures. Cross-sectional 
and longitudinal MRI scans of the brain suggest more variable patterns. Brain volume  
appears to increase in the ﬁrst part of life presumably due to myelination and axonal growth 
but before the maturational changes are complete, degeneration due to selective loss of small-
diameter myelinated axons (primary degenerative event) and demyelination of larger 
connections (secondary degenerative event) occurs. The superimposed effect of both 
processes result in an early period whereby the volume increase slowly decelerates and a later 
period, where volume reduction begins to level off.92 Different brain structures, however, 
showed different trajectories; the hippocampus showed a plateau and then accelerated loss 
pattern whilst the cerebral cortex had a simple linear decline (at least from age 20 years). 
 
Physiological, psychological and social resilience 
We know there is great heterogeneity in biological ageing and our models, to be of any value, 
need to be able to take into account this variation in resilience to environmental challenges 
with age. The ability to repair and compensate was referred to by Martin93  as “sageing” 
though he considered this to only occur in the phase between that of the mature, reproducing 
adult and the senescing adult. We would argue that this view is too limited and in fact this can 
occur throughout life though the relative ease and ability to compensate may well differ 
(sensitive periods) and is generally regarded to decline with age known as “homeostenosis”.94 
A life course approach is particularly interested in understanding the relationship between the 
growth, plateau and degeneration phases. Are they independent or do similar or different risk 
factors determine them? Is there an interaction between these phases and clinical disease or 
functional limitations? 
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One obvious relationship is the role of what we have previously described as structural 
reserve; those with better development of a phenotype (e.g. lung function, bone mass, 
cognitive capability) will have further to decline before reaching any impairment threshold 
and hence will present with disease at a later age or may never present if they die of another 
cause. In our original figure this was illustrated by the peak level of function at the plateau 
phase. We failed to illustrate the ability to recover from adverse exposures and how this 
changes with age, what we now term as compensatory reserve (see figure 5). Whilst such 
short term responses will be beneficial, there may or may not be longer term costs in relation 
to ageing. McEwen and Wingfield called this longer term adverse effect as type 2 chronic 
allostatic load.95 
 
Thus, the degree of heart failure subsequent to a heart attack will not only depend on the size 
of the infarction and how healthy it was prior to this event (pre-morbid state) but also the 
post-ischaemic response in generating collateral circulation thereby salvaging cardiac muscle 
and function. Intrinsic compensatory reserve may or may not be related to structural reserve, 
an empirical question that requires attention. For example, does recovery post-stroke relate to 
developmental pre-stroke synaptic connectivity or does it merely reflect acute central repair 
processes? Similarly, is age-related loss of immune responsiveness to novel antigens related 
to the degree of immunostimulation in early life? In order to capture adaptive responses, it is 
necessary to physiologically stress the system.  This may be a natural process, as seen in the 
rise in cortisol levels on waking (cortisol awakening response) or through a standardised 
exposure such as the oral glucose tolerance test to measure glucose and insulin responsiveness 
to a standard intake. Few studies have made use of other opportunistic dynamic exposures, 
such as immune responsiveness to flu vaccination,96 blood pressure decline to anti-
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hypertensive agents, or recovery from an acute event such as illness or surgery. A recent 
interesting exemplar was a study of the impact of acute stroke on longitudinal cognitive 
trajectories.97 Three distinct patterns emerged: (a) acute decline but no change in age-related 
decline (seen with word learning list and recall); (b) accelerated age-related decline (seen with 
executive function); and (c) both acute decline and accelerated age-related decline (seen with 
global cognition).  
 
Old age is obviously associated with greater morbidity often necessitating major health care 
interventions. Recent evidence highlights the predictive value of the pre-admission physical 
trajectory in predicting one year survival after an acute illness resulting in an intensive care 
unit episode.98 Greater understanding of how functional trajectories predict clinical outcomes 
would enhance precision medicine. Better selection of those who have most to benefit from 
an intervention would not only reduce health care expenditure but avoid unnecessary and 
often invasive procedures for patients and families. Other predictors of post-surgical 
outcomes also illustrate the often paradoxical nature of mid-life risk factors in older 
populations. Whilst being overweight and obese in mid-life increases premature mortality 
risk, at older ages both are associated with reduced post-operative mortality compared to 
normal weight after elective joint replacement.99 100  Whether this reflects a healthy survivor 
effect, confounding by co-morbidity101 and smoking status or a genuinely protective effect of 
greater lean mass, which is positively correlated with fat mass, in response to the acute trauma 
of surgery remains to be determined.  
 
In parallel, how an individual responds to adversity will result in extrinsic compensatory 
adaptations which may be facilitated or hindered by the external environment. Baltes 
proposed a metatheory known as the selective optimization and compensation (SOC) model 
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to understand human development. In addition he stated “with age, and conditioned primarily 
by the negative biological trajectory of the life course, the relative power (effectiveness) of 
psychological, social, material, and cultural interventions wanes.”91  This ability of 
individuals to optimise and compensate will be determined by a variety of factors; 
psychological trait (self-efficacy), educational resources (health literacy), material resources 
(socioeconomic position), familial and social resources (inter-connectedness) and 
geographical factors acting at household, neighbourhood and locality. For example, higher 
socioeconomic position, social networks and residential location may facilitate engagement 
with intellectual pursuits which in turn could maintain synaptic connectivity, through 
cognitive stimulation, hence slow down decline or maintain cognitive function, independent 
of cognitive reserve, in the presence of underlying neurodegeneration. 
 
Variability over varying timescales 
The other limitation of  our illustration of different trajectory patterns is that this merely 
represents the mean trajectory and fails to illustrate variability (measured over seconds, 
minutes, hours, days, weeks) which may provide added predictive value for phenotypic 
integrity. Blood pressure variability for a given identical mean level independently increases 
risk of cardiovascular disease102 possibly because it is a marker of arterial stiffness which 
predicts cardiovascular morbidity independent of mean blood pressure103 or is also a marker 
of failing central homeostatic mechanisms that maintain blood pressure within a limited 
range. Similar observations have been seen for gait speed in older populations in which a 
larger standard deviation of gait speed rather than mean level predicts future falls risk104 and 
probably reflects underlying neurological dysfunction. Past epidemiological studies have not 
been able to capture variability, especially on a day-to-day basis, because of the prohibitive 
cost and respondent burden except in small scale detailed studies. New technologies now 
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make this a feasible proposition although our understanding of the life course determinants of 
such compensatory responses is currently limited. Whether these are modifiable is clearly 
important; we know from the LIFE trial that increased physical activity in high risk older 
people can reduce the incidence of mobility disability although this was not associated with a 
reduction in hospitalization.105 
 
Current challenges of life course epidemiology  
This review has shown that the field of life course epidemiology has a healthy scientific 
agenda focused on understanding how different aspects of function change (at the individual, 
system and cellular level) across life, and discovering their lifetime risk factors, mediators, 
modifiers and consequences. Much of this agenda is shared with our colleagues in DOHaD, in 
ageing research (see commentary by Newman106) and in geroscience (see commentary by 
Ferrucci107 108) and we believe our complementary approaches add value and hence should be 
further integrated. This scientific agenda attracts researchers from many disciplines, and the 
demographic pressures of an ageing population on health and social care should ensure a 
parallel political agenda on the importance for these research streams.  
 
A healthy scientific agenda ensures continuing technological developments which in turn 
provide new opportunities for life course epidemiology, and epidemiology more generally. 
We give a few examples. Technology or “digital epidemiology”109 increasingly allows us to 
capture real time dynamic assessments of function, environment and behaviour which provide 
additional information on short term variability within the context of long-term change. There 
are growing opportunities for exploiting record linkage, assuming ethical issues and consents 
have been addressed, which reduce respondent burden and inherent problems of self-
reporting. This has additional added value in enhancing analyses that incorporate missing 
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data, always an in issue in any longitudinal study, and help produce less biased estimates of 
effect as seen recently with data from the ALSPAC study.110  
 
A priority is to find ways to capture the care pathways and the interactions between 
individuals and their experience of health and social care that may shape future functional 
trajectories; for example how dynamic events, such as acute illness, and the care received at 
that time, punctuate trajectories of decline in later life.111 Life course and longitudinal 
methods are being used to harness the ‘omics revolution to this scientific agenda in the hope 
that new aetiological insights into underlying biological pathways linking earlier exposures to 
later function will be generated 112  and new quantitative biomarker profiles will predict age-
related functional change and disease development (also see IJE special editions on 
epigenetics and mendelian randomization50 113). Any future review of life course 
epidemiology will need to evaluate the success of these approaches in addressing these 
scientific questions.   
 
Past, current and future developments in life course epidemiology and in life course cohorts 
are intimately intertwined: since the 1990s, there has been a ‘feast’ in terms of the growing 
number of cohorts with increasingly rich data archives (social and biomedical) for testing life 
course hypotheses; this has helped to maintain and continually evolve the scientific agenda 
(see editorial by Brayne114). We see a number of challenges ahead for cohort studies in a time 
of financial austerity. Each cohort study must justify its scientific niche, as well as maximise 
its value from cross cohort collaborations, especially with the rise of large biobank studies.  In 
the ideal world, both types of study are required as they are complementary, but in the real 
world they compete for limited resources. Recent cuts to cohort funding and/or challenges in 
participant recruitment are cause for concern115 116 and will do little to attract a new 
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generation of primary investigators to invest in cohort management, collect and assess data 
quality, and incorporate new life course methods of statistical analysis so that the benefits of 
longitudinal data on more granular exposure and outcome data can be best realised.   
 
Another challenge is to translate the growing body of evidence on the lifetime influences on 
adult health, disease and ageing into practice or policy-relevant guidelines and intervention 
studies to improve the population health117 (see commentaries by Boyce and Shonkoff38 and 
Aihie Sayer and Gill118). Strategic and policy documents increasingly espouse a life course 
perspective and cite evidence from cohort studies, though this is usually within an early life 
remit focussing on maternal and child health,17 119 both important areas in their own right.  
However, some research funders, policy makers and governments consider that the 
translational agenda is not moving fast enough. Life course epidemiology has mainly relied 
on observational studies or rarely the opportunistic long-term follow-up of randomised 
controlled trials88 120 121 It may also be that the implications from life course research, for 
example about the long-term effects of adverse socioeconomic and psychosocial 
environments, may not be attractive to politicians who seek short term wins that are 
achievable within an electoral cycle. Finally it is important to remember that some life course 
findings may be highly context specific both in time and place making generalising from 
observations to policy formulation problematic. Systematic reviews and cross-cohort 
comparisons are important and necessary pre-requisites before assuming immediate policy 
relevance.122 123 
 
An eminent professor of epidemiology once commented, after one of our presentations, that 
whilst they really liked the concepts underpinning life course epidemiology, they were 
concerned that the data and analytical demands in testing these concepts may make our goals 
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unachievable. We have always shared this concern but have been encouraged by the 
enthusiasm of researchers in rising to this challenge. We believe that in this new era of “big 
data” and genuine multi-disciplinary research groups with new disciplinary partners, such as 
computer scientists, engineers and mathematicians, we are in a far healthier place to take on 
these complexities. The new discoveries emerging from the ‘omics revolution need to go hand 
and hand with historical, current and future cohort studies thereby allowing us to understand 
the interplay of molecular, system, individual and societal factors on development and 
maintenance of health and function as well as disease aetiology. 
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TEXT BOX: Reviewing the published literature 
 
To assess developments in life course epidemiology since the inception of this term in 1997, we 
aimed to capture relevant papers published in this area up to the end of 2014 using two searches 
(undertaken in February and March 2015): 
1) A cited reference search of four  publications on life course epidemiology (from the date of their 
publication to 31st December 2014):  
I. Kuh D and Ben Shlomo Y (editors). A Life Course Approach to Chronic Disease Epidemiology. 
1st edition. Oxford University Press, Oxford, UK. 1997. 
II. Kuh D and Ben Shlomo Y (editors). A Life Course Approach to Chronic Disease Epidemiology. 
2nd edition. Oxford University Press, Oxford, UK. 2004. 
III. Ben-Shlomo Y and Kuh D. A life course approach to chronic disease epidemiology: conceptual 
models, empirical challenges and interdisciplinary perspectives. Int J Epidemiol 
2002;31(2):285-93 
IV. Kuh D, Ben-Shlomo Y, Lynch J, Hallqvist J and Power C. Life course epidemiology. J Epidemiol 
Community Health 2003;57(10):778-83 
 
2) A free text search to identify all literature indexed in Medline which: 
 included the term: life course (i.e. “life ADJ course” or “life-course” or “lifecourse”), in the 
title or abstract  
 was published between 1st January 1990 and 31st December 2014.   
 was published in English language and indexed as study of humans 
 
To enable us to draw comparisons with developments in the Developmental Origins of Health and 
Disease (DOHaD) we undertook a third search (in March 2015): 
3) A free text search to identify all literature indexed in Medline which: 
 included the term: ‘developmental origin*’ OR ‘fetal origin*’ OR ‘foetal origin*’ in the title or 
abstract  
 was published between 1st January 1990 and 31st December 2014.   
 was published in English language and indexed as study of humans 
 
The results of each of these searches were downloaded to reference management software and 
duplicates were removed. See supplementary figure 1 for number of search results returned. 
Each result from search 2 was screened and classified by YBS, RC or DK using standard criteria based 
on its relevance, type of paper, outcome, exposure and analyses, timing of exposures and setting. 
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See text box for details of three literature searches 
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Figure legends 
Figure 1: Venn diagram showing overlap between search results  
Figure 2: Number of publications identified by literature searches 1 and 2 by 
publication year 
Figure 3: Testing for evidence of accumulation or sensitive period effects in models of 
the association between smoking pack years and risk of breast cancer  
Figure 4: An integrated life course model of ageing 
Taken from: Kuh et al. A life course approach to healthy ageing (OUP, 2014) 
Need to request permission from OUP to reprint 
Figure 5: The influence of structural and compensatory reserve and adaptations on a 
life course trajectory  
[For figures 2-5 please see accompanying ppt file] 
 
 
APPENDICES 
Supplementary Figure 1: Flow diagram of literature search results 
Supplementary Tables 1 and 2: Summary of findings from classification of literature 
search results 
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